c-Jun N-TERMINAL KINASE BINDING DOMAIN-DEPENDENT PHOSPHORYLATION OF MITOGEN-ACTIVATED PROTEIN KINASE KINASE 4 AND MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7 AND BALANCING CROSS-TALK BETWEEN c-Jun N-TERMINAL KINASE AND EXTRACELLULAR SIGNAL-REGULATED KINASE PATHWAYS IN CORTICAL NEURONS

被引:37
|
作者
Repici, M. [2 ]
Mare, L. [2 ]
Colombo, A. [1 ]
Ploia, C. [1 ]
Sclip, A. [1 ]
Bonny, C. [3 ]
Nicod, P. [3 ]
Salmona, M. [1 ]
Borsello, T. [1 ,2 ]
机构
[1] Ist Ric Farmacol Mario Negri, Biol Neurodeg Disorders Lab, Neuronal Death & Neuroprotect Unit, I-20156 Milan, Italy
[2] Univ Lausanne, Dept Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland
[3] CHU Vaudois, Dept Internal Med, CH-1011 Lausanne, Switzerland
基金
瑞士国家科学基金会;
关键词
JNK; MKK4; MKK7; ERK; MEK1; D-JNKI1; PEPTIDE INHIBITOR; CELL-DEATH; DOCKING SITES; NH2-TERMINAL KINASE; CEREBRAL-ISCHEMIA; DOWN-REGULATION; HEARING-LOSS; JNK; TRANSDUCTION; INJURY;
D O I
10.1016/j.neuroscience.2008.11.049
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The c-Jun N-terminal kinase (JNK) is a mitogen-activated protein kinase (MAPK) activated by stress-signals and involved in many different diseases. Previous results proved the powerful effect of the cell permeable peptide inhibitor D-JNKI1 (D-retro-inverso form of c-Jun N-terminal kinase-inhibitor) against neuronal death in CNS diseases, but the precise features of this neuroprotection remain unclear. We here performed cell-free and in vitro experiments for a deeper characterization of D-JNKI1 features in physiological conditions. This peptide works by preventing JNK interaction with its c-Jun N-terminal kinase-binding domain (JBD) dependent targets. We here focused on the two JNK upstream MAPKKs, mitogen-activated protein kinase kinase 4 (MKK4) and mitogen-activated protein kinase kinase 7 (MKK7), because they contain a JBD homology domain. We proved that D-JNKI1 prevents MKK4 and MKK7 activity in cell-free and in vitro experiments: these MAPKK could be considered not only activators but also substrates of JNK. This means that D-JNKI1 can interrupt downstream but also upstream events along the JNK cascade, highlighting a new remarkable feature of this peptide. We also showed the lack of any direct effect of the peptide on p38, MEK1, and extracellular signal-regulated kinase (ERK) in cell free, while in rat primary cortical neurons JNK inhibition activates the MEK1-ERK-Ets1/c-Fos cascade. JNK inhibition induces a compensatory effect and leads to ERK activation via MEK1, resulting in an activation of the survival pathway(MEK1/ERK) as a consequence of the death pathway-(JNK) inhibition. This study should hold as an important step to clarify the strong neuroprotective effect of D-JNKI1. (C) 2009 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:94 / 103
页数:10
相关论文
共 50 条
  • [1] Gαq-dependent activation of mitogen-activated protein kinase kinase 4/c-Jun N-terminal kinase cascade
    Yamauchi, J
    Itoh, H
    Shinoura, H
    Miyamoto, Y
    Tsumaya, K
    Hirasawa, A
    Kaziro, Y
    Tsujimoto, G
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 288 (05) : 1087 - 1094
  • [2] Mitogen-activated protein kinase kinase kinase kinase 4 as a putative effector of Rap2 to activate the c-Jun N-terminal kinase
    Machida, N
    Umikawa, M
    Takei, K
    Sakima, N
    Myagmar, BE
    Taira, K
    Uezato, H
    Ogawa, Y
    Kariya, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (16) : 15711 - 15714
  • [3] Probenecid Inhibits Extracellular Signal-Regulated Kinase and c-Jun N-Terminal Kinase Mitogen-Activated Protein Kinase Pathways in Regulating Respiratory Syncytial Virus Response
    Jones, Les P.
    Bergeron, Harrison C.
    Martin, David E.
    Murray, Jackelyn
    Sancilio, Fred D.
    Tripp, Ralph A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (22)
  • [4] Regulation of inflammatory arthritis by the upstream kinase mitogen activated protein kinase kinase 7 in the c-Jun N-Terminal kinase pathway
    Lee, Sang-il
    Boyle, David L.
    Berdeja, Andres
    Firestein, Gary S.
    ARTHRITIS RESEARCH & THERAPY, 2012, 14 (01)
  • [5] Regulation of inflammatory arthritis by the upstream kinase mitogen activated protein kinase kinase 7 in the c-Jun N-Terminal kinase pathway
    Sang-il Lee
    David L Boyle
    Andres Berdeja
    Gary S Firestein
    Arthritis Research & Therapy, 14
  • [6] Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis
    Hammaker, DR
    Boyle, DL
    Chabaud-Riou, M
    Firestein, GS
    JOURNAL OF IMMUNOLOGY, 2004, 172 (03): : 1612 - 1618
  • [7] Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase
    Tournier, C
    Whitmarsh, AJ
    Cavanagh, J
    Barrett, T
    Davis, RJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (14) : 7337 - 7342
  • [8] Extracellular signal-regulated kinase and c-Jun N-terminal protein kinase in ischemic tolerance
    Gu, ZL
    Jiang, Q
    Zhang, GY
    NEUROREPORT, 2001, 12 (16) : 3487 - 3491
  • [9] Sequential activation of mitogen activated protein kinase and c-Jun N-terminal kinase by acetaldehyde in hepatocytes
    Lee, YJ
    Aroor, AR
    Weng, YJ
    Shukla, SD
    FASEB JOURNAL, 2001, 15 (04): : A571 - A571
  • [10] Stress- and cell type-dependent regulation of transfected c-Jun N-terminal kinase and mitogen-activated protein kinase kinase isoforms
    Butterfield, L
    Zentrich, E
    Beekman, A
    Heasley, LE
    BIOCHEMICAL JOURNAL, 1999, 338 : 681 - 686